{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-076433","form_type":"8-K","ticker":"CCEL","cik":"0000862692","company_name":"CRYO CELL INTERNATIONAL INC","filed_at":"2025-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.501403+00:00","generated_at":"2026-05-20T19:49:58.711614+00:00","sec_items":["1.02"],"event_type":"litigation","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Duke terminates patent license with Cryo-Cell effective May 17; Cryo-Cell previously sought arbitration","bullets":["Duke University terminated Patent and Technology License Agreement effective May 17, 2025, claiming Cryo-Cell breached.","Cryo-Cell had previously filed a demand for arbitration against Duke, alleging fraudulent inducement and breach.","The license granted Cryo-Cell exclusive rights to commercialize certain products and processes for human disease treatment.","Termination could impact Cryo-Cell's ability to commercialize the licensed technology; arbitration is ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-076433","json":"https://secwatch.observer/filing/0000950170-25-076433.json","markdown":"https://secwatch.observer/filing/0000950170-25-076433.md","text":"https://secwatch.observer/filing/0000950170-25-076433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/862692/000095017025076433/0000950170-25-076433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/862692/000095017025076433/ccel-20250517.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T19:49:58.711614+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}